Invesaro

Stocks JCI Financial statements

Financial statements

Johnson Controls International plc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Johnson Controls International plc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue20,83730,17231,40023,96822,31723,66820,63722,33122,95223,596
Cost of revenue15,18315,30515,73316,27514,90615,60913,54714,52714,87515,004
Gross profit5,6547,5307,6677,6937,4118,0597,0907,8048,0778,592
Research and development158307310319274275236251267273
Selling, general and administrative4,1905,7235,6426,2445,6655,2585,0785,3875,6615,764
Interest expense293446409335240219225
Pre-tax income1,0611,1511,5461,0569032,6141,1121,1131,5221,969
Income tax197322197-233108868-182-468111245
Income from continuing operations7326721,1751,1006311,5131,2791,5621,4071,721
Net income to minority interests164233191184195222
Net income-8681,6112,1625,6746311,6371,5321,8491,7053,291
EPS, basic-1.301.722.346.520.842.282.202.702.535.04
EPS, diluted-1.291.712.326.490.842.272.192.692.525.03
Shares, basic (weighted)667935926870751717696684674652
Shares, diluted (weighted)673945932874754721700687676654
Dividend per share1.161.001.041.041.041.071.391.451.481.51

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents5793011852,8051,9511,3362,029828606379
Receivables6,3946,6665,6225,7705,2945,6135,7275,4946,0516,269
Inventory2,8883,2091,8191,8141,7732,0572,6651,8721,7741,820
Other current assets1,4361,9071,1821,9061,0359921,2629911,1531,680
Total current assets17,10912,29211,82312,39310,0539,99811,68510,73711,17910,162
Property, plant and equipment5,6323,3413,3003,3483,0593,2282,2712,3742,4032,193
Lease right-of-use assets1,3761,2711,3011,1701,347
Goodwill21,02418,59118,38118,17817,93218,33516,17516,77216,72516,633
Intangible assets7,5406,7416,1875,6325,3565,5495,1554,7724,1303,613
Other non-current assets3,5103,9313,0701,8233,3543,5583,8744,4825,0485,198
Total assets63,17951,88448,79742,28740,81541,89042,15842,24242,69537,939
Accounts payable4,0004,2713,4073,5823,1203,7464,3683,4983,3893,614
Accrued liabilities1,3331,0711,0219538381,0081,0038471,0481,268
Deferred revenue1,2281,2791,3261,4071,4351,6371,8041,9232,1602,470
Short-term debt6283941501262226865645536566
Total current liabilities16,33111,85411,2509,0708,2489,09811,23911,08411,95510,941
Long-term debt11,05311,9649,6236,7087,5267,5067,4267,8188,0048,591
Lease liabilities1,0559871,0169211,084
Other non-current liabilities5,0335,3684,6434,6365,3685,9055,7334,9874,7535,233
Total liabilities38,08930,51726,33921,45822,28223,13724,75624,54825,33424,985
Total debt11,68112,3589,6247,2097,7887,7328,2918,4628,5689,195
Paid-in capital16,10516,39016,54916,81216,86517,11617,22417,34917,47514,865
Retained earnings9,1775,2316,6044,8272,4692,0251,1511,3848480
Treasury stock-20-710-1,053-1,086-1,119-1,152-1,203-1,240-1,268-1,302
Other comprehensive income-1,153-473-946-795-776-434-911-955-964-642
Shareholders' equity24,11820,44721,16419,76617,44717,56216,26816,54516,09812,927
Minority interests9729201,2941,0631,0861,1911,1341,1491,26327
Total equity25,09021,36722,45820,82918,53318,75317,40217,69417,36112,954
Total liabilities and equity63,17951,88448,79742,28740,81541,89042,15842,24242,69537,939

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-6521,8192,3835,8877951,8701,7232,0331,9003,513
Depreciation and amortization953919824825822845717745816865
Stock-based compensation14213410695747698107107140
Deferred income tax-765573-739612-53736-191-650-407194
Change in receivables-344-225-475-312534-143-409-259-537-211
Change in inventory1-51-103-7245-219-539-58-17-75
Change in payables411-13034056-717813847-85645694
Cash from operations1,9083711,5201,7432,4792,5511,2371,8561,5682,554
Capital expenditures-1,249-760-645-586-443-552-487-446-494-434
Acquisitions353-6-21-25-77-725-269-726-3-10
Sales and maturities of investments3
Cash from investing-887-6481,568-533-258-1,090-693-1,184-184-412
Debt issued7341,7711,1731,2811,765
Debt repaid-1,299-1,275-3,704-2,333-1,386-507-184-1,555-924-1,648
Stock issued7015766171751781742
Share buybacks-501-651-300-5,983-2,204-1,307-1,441-625-1,246-5,991
Dividends paid-915-702-954-920-790-762-916-980-1,000-976
Cash from financing-946-649-3,749-10,519-2,824-2,131-516-2,174-1,948-6,784
Exchange rate effect1254-106-120115116-53-559-259
Net change in cash26-322-1322,621-861-618725-1,147-150-369
Free cash flow659-3898751,1572,0361,9997501,4101,0742,120
Interest paid319432401369247242222288361321
Income taxes paid1,38849781377-386504439294704606

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $150.20 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin36.6%Gross profit / revenue.
Pre-tax margin10.3%Pre-tax income / revenue.
Net margin14.5%Net income / revenue.
FCF margin10.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin12.4%Cash from operations / revenue.
Effective tax rate18.0%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)26.1%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)9.2%Net income / average total assets.
SG&A / revenue22.8%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.6%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.5%Capital expenditures / revenue.
D&A / revenue3.3%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y2.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y4.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y1.1%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y6.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y6.6%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y3.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y93.0%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y29.0%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y39.1%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y99.6%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y31.9%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y43.0%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y62.9%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y27.3%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y0.6%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y97.4%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y41.4%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y0.8%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y2.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y2.8%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y7.7%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-19.7%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-7.4%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-5.8%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-11.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-3.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-1.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-3.2%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-2.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-2.8%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.04xCurrent assets / current liabilities.
Quick ratio0.69x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.07x(Cash + short-term investments) / current liabilities.
Debt / equity0.64xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets22.5%Total debt / total assets.
Liabilities / assets64.7%Total liabilities / total assets.
Net debt$7.94BTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital$386.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets52.2%(Goodwill + intangible assets) / total assets.
Tangible book value-$6.51BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.64xRevenue / average total assets.
Fixed asset turnover11.7xRevenue / average property, plant and equipment.
Inventory turnover8.02xCost of revenue / average inventory.
Days inventory46 days365 x average inventory / cost of revenue.
Receivables turnover3.69xRevenue / average receivables.
Days sales outstanding99 days365 x average receivables / revenue.
Days payables85 days365 x average accounts payable / cost of revenue.
Cash conversion cycle59 daysDays inventory + days sales outstanding - days payables.
FCF conversion75.5%Free cash flow / net income, when net income is positive.
Capex / operating cash flow12.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$5.75Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$39.79Revenue / diluted weighted shares.
FCF per share$4.34Free cash flow / diluted weighted shares.
Operating cash flow per share$4.95Cash from operations / diluted weighted shares.
Book value per share$22.02Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$10.61Tangible book value / shares outstanding.
Cash per share$1.14(Cash + short-term investments) / shares outstanding.
Payout ratio27.6%Dividends paid / net income, when net income is positive.
Dividends / FCF36.6%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF208.0%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$90.98BShare price x shares outstanding.
Enterprise value$98.93BMarket cap + total debt - cash - short-term investments.
P/E25.8xMarket cap / net income. Only when net income is positive.
P/S3.72xMarket cap / revenue.
P/B6.73xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF34.1xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF29.9xMarket cap / cash from operations, when positive.
EV/Sales4.05xEnterprise value / revenue.
EV/FCF37.1xEnterprise value / free cash flow, when both are positive.
FCF yield2.9%Free cash flow / market cap.
Earnings yield3.9%Net income / market cap (the inverse of P/E).
Dividend yield1.1%Dividends paid over the period / market cap.
Shareholder yield7.2%(Dividends paid + share buybacks) / market cap.
PEG0.81xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was Johnson Controls International plc's revenue in fiscal 2025?

Johnson Controls International plc reported revenue of $23.60B for fiscal 2025, 2.8% higher than the year before.

Was Johnson Controls International plc profitable in fiscal 2025?

Yes. Net income was $3.29B, a net margin of 13.9%.

How much free cash flow did Johnson Controls International plc generate in fiscal 2025?

Cash from operations of $2.55B minus capital expenditures of $434.0M left free cash flow of $2.12B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Johnson Controls International plc